224 related articles for article (PubMed ID: 36445237)
1. m6A methyltransferase METTL3 inhibits endometriosis by regulating alternative splicing of MIR17HG.
Li Q; Yang L; Zhang F; Liu J; Jiang M; Chen Y; Ren C
Reproduction; 2023 Feb; 165(2):197-208. PubMed ID: 36445237
[TBL] [Abstract][Full Text] [Related]
2. METTL3-mediated m6A modification of SIRT1 mRNA inhibits progression of endometriosis by cellular senescence enhancing.
Wang X; Wang J; Zhao X; Wu H; Li J; Cheng Y; Guo Q; Cao X; Liang T; Sun L; Zhang G
J Transl Med; 2023 Jun; 21(1):407. PubMed ID: 37353804
[TBL] [Abstract][Full Text] [Related]
3. METTL3-regulated m6A modification impairs the decidualization of endometrial stromal cells by regulating YTHDF2-mediated degradation of FOXO1 mRNA in endometriosis-related infertility.
Li X; Jin J; Long X; Weng R; Xiong W; Liang J; Liu J; Sun J; Cai X; Zhang L; Liu Y
Reprod Biol Endocrinol; 2023 Oct; 21(1):99. PubMed ID: 37891533
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of METTL3/m6A/miR126 promotes the migration and invasion of endometrial stromal cells in endometriosis†.
Li X; Xiong W; Long X; Dai X; Peng Y; Xu Y; Zhang Z; Zhang L; Liu Y
Biol Reprod; 2021 Nov; 105(5):1221-1233. PubMed ID: 34382070
[TBL] [Abstract][Full Text] [Related]
5. METTL3 is aberrantly expressed in endometriosis and suppresses proliferation, invasion, and migration of endometrial stromal cells.
Zhang QC
Kaohsiung J Med Sci; 2023 Mar; 39(3):266-277. PubMed ID: 36546578
[TBL] [Abstract][Full Text] [Related]
6. METTL3 regulates alternative splicing of MyD88 upon the lipopolysaccharide-induced inflammatory response in human dental pulp cells.
Feng Z; Li Q; Meng R; Yi B; Xu Q
J Cell Mol Med; 2018 May; 22(5):2558-2568. PubMed ID: 29502358
[TBL] [Abstract][Full Text] [Related]
7. METTL3-mediated m6A modification is required for cerebellar development.
Wang CX; Cui GS; Liu X; Xu K; Wang M; Zhang XX; Jiang LY; Li A; Yang Y; Lai WY; Sun BF; Jiang GB; Wang HL; Tong WM; Li W; Wang XJ; Yang YG; Zhou Q
PLoS Biol; 2018 Jun; 16(6):e2004880. PubMed ID: 29879109
[TBL] [Abstract][Full Text] [Related]
8. Methyltransferase-like 3 facilitates lung cancer progression by accelerating m6A methylation-mediated primary miR-663 processing and impeding SOCS6 expression.
Li S; Lu X; Zheng D; Chen W; Li Y; Li F
J Cancer Res Clin Oncol; 2022 Dec; 148(12):3485-3499. PubMed ID: 35907010
[TBL] [Abstract][Full Text] [Related]
9. The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1.
Miao W; Chen J; Jia L; Ma J; Song D
Biochem Biophys Res Commun; 2019 Aug; 516(3):719-725. PubMed ID: 31253399
[TBL] [Abstract][Full Text] [Related]
10. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
[TBL] [Abstract][Full Text] [Related]
11. METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.
Ai Y; Liu S; Luo H; Wu S; Wei H; Tang Z; Li X; Lv X; Zou C
J Immunol Res; 2021; 2021():6149558. PubMed ID: 34476262
[TBL] [Abstract][Full Text] [Related]
12. METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.
Xie W; Ma LL; Xu YQ; Wang BH; Li SM
Biochem Biophys Res Commun; 2019 Oct; 518(1):120-126. PubMed ID: 31405565
[TBL] [Abstract][Full Text] [Related]
13. METTL3 (Methyltransferase Like 3)-Dependent N6-Methyladenosine Modification on
Li Q; Yu L; Gao A; Ren R; Zhang J; Cao L; Wang X; Liu Y; Qi W; Cai L; Li W; Wang W; Guo X; Su G; Yu X; Zhang J; Xi B; Zhang Y; Zhang M; Zhang C
Arterioscler Thromb Vasc Biol; 2023 May; 43(5):755-773. PubMed ID: 36951060
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of METTL3 expression and m6A RNA methylation in placental trophoblasts in preeclampsia.
Gu Y; Chu X; Morgan JA; Lewis DF; Wang Y
Placenta; 2021 Jan; 103():43-49. PubMed ID: 33070036
[TBL] [Abstract][Full Text] [Related]
15. METTL3 promotes prostate cancer progression by regulating miR-182 maturation in m6A-dependent manner.
Wang D; Wang X; Huang B; Zhao Y; Tu W; Jin X; Shao Y; Zhu Y; Lu G
Andrologia; 2022 Aug; 54(7):1581-1591. PubMed ID: 35413135
[TBL] [Abstract][Full Text] [Related]
16. m6A-related bioinformatics analysis and functional characterization reveals that METTL3-mediated NPC1L1 mRNA hypermethylation facilitates progression of atherosclerosis via inactivation of the MAPK pathway.
Zhang G; Li X; Huang X
Inflamm Res; 2023 Mar; 72(3):429-442. PubMed ID: 36583755
[TBL] [Abstract][Full Text] [Related]
17. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway.
Cui X; Wang Z; Li J; Zhu J; Ren Z; Zhang D; Zhao W; Fan Y; Zhang D; Sun R
Cell Prolif; 2020 Mar; 53(3):e12768. PubMed ID: 31967701
[TBL] [Abstract][Full Text] [Related]
18. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
[TBL] [Abstract][Full Text] [Related]
19. METTL14 is a chromatin regulator independent of its RNA N6-methyladenosine methyltransferase activity.
Dou X; Huang L; Xiao Y; Liu C; Li Y; Zhang X; Yu L; Zhao R; Yang L; Chen C; Yu X; Gao B; Qi M; Gao Y; Shen B; Sun S; He C; Liu J
Protein Cell; 2023 Sep; 14(9):683-697. PubMed ID: 37030005
[TBL] [Abstract][Full Text] [Related]
20. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
